Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8233 ARTÍCULOS , VIENDO DEL 1531 AL 1545

Advances in Antioxidant Nanomedicines for Imaging and Therapy of Alzheimer's Disease

Hasan I, Guo B, Zhang J, Chang C.

Antioxid Redox Signal. 2024 May;40(13-15):863-888. doi: 10.1089/ars.2022.0107. Epub 2023 Feb 23.

Extravaganza of Nanobiotechnology in the Diagnosis and Treatment of Dementia Patients

Bhattacharya S.

Curr Pharm Biotechnol. 2023;24(9):1108-1121. doi: 10.2174/1385272827666221027103050.

Characterization of exposure-Clinical Dementia Rating-Sum of Boxes relationship in subjects with early Alzheimer's disease from the aducanumab Phase 3 trials

Muralidharan KK, Kowalski KG, Tong X, Haeberlein SB, Rajagovindan R, Nestorov I.

J Pharmacokinet Pharmacodyn. 2023 Feb;50(1):45-62. doi: 10.1007/s10928-022-09839-3. Epub 2023 Jan 4.

A Review of Scientific Ethics Issues Associated with the Recently Approved Drugs for Alzheimer's Disease

Yeo-Teh NSL, Tang BL.

Sci Eng Ethics. 2023 Jan 10;29(1):2. doi: 10.1007/s11948-022-00422-0.

A systematic study of nano-based fibrous systems: Diagnostic and therapeutic approaches for dementia control

Chehrehgosha M, Khoshnevisan K, Maleki H, Baharifar H, Meftah AM, Sajjadi-Jazi SM, Sharifi F.

Ageing Res Rev. 2023 Mar;85:101853. doi: 10.1016/j.arr.2023.101853. Epub 2023 Jan 13.

A Review on the Natural Components Applied as Lead Compounds for Potential Multi-target Anti-AD Theranostic Agents

Kou X, Shi X, Pang Z, Yang A, Shen R, Zhao L.

Curr Med Chem. 2023;30(40):4586-4604. doi: 10.2174/0929867330666230125153027.

Distinguishing apathy from depression: A review differentiating the behavioral, neuroanatomic, and treatment-related aspects of apathy from depression in neurocognitive disorders

Lanctôt KL, Ismail Z, Bawa KK, Cummings JL, Husain M, Mortby ME, Robert P.

Int J Geriatr Psychiatry. 2023 Feb;38(2):e5882. doi: 10.1002/gps.5882.

FDA approval of lecanemab: the real start of widespread amyloid PET use? - the EANM Neuroimaging Committee perspective

Verger A, Yakushev I, Albert NL, van Berckel B, Brendel M, Cecchin D, Fernandez PA, Fraioli F, Guedj E, Morbelli S, Tolboom N, Traub-Weidinger T, Van Weehaeghe D, Barthel H.

Eur J Nucl Med Mol Imaging. 2023 May;50(6):1553-1555. doi: 10.1007/s00259-023-06177-5.

Efficacy and safety of a transdermal donepezil patch in patients with mild-to-moderate Alzheimer's disease: A 24-week, randomized, multicenter, double-blind, parallel group, non-inferiority study

Nakamura Y, Kim R, Nishiyama K, Kikuchi T, Ishikawa I, Aoki H.

Geriatr Gerontol Int. 2023 Apr;23(4):275-281. doi: 10.1111/ggi.14566. Epub 2023 Mar 9.

Suvorexant Acutely Decreases Tau Phosphorylation and Aβ in the Human CNS

Lucey BP, Liu H, Toedebusch CD, Freund D, Redrick T, Chahin SL, Mawuenyega KG, Bollinger JG, Ovod V, Barthélemy NR, Bateman RJ.

Ann Neurol. 2023 Jul;94(1):27-40. doi: 10.1002/ana.26641. Epub 2023 Apr 20.

Longitudinal Exposure-Response Modeling of Multiple Indicators of Alzheimer's Disease Progression

Polhamus DG, Dolton MJ, Rogers JA, Honigberg L, Jin JY, Quartino A.

J Prev Alzheimers Dis. 2023;10(2):212-222. doi: 10.14283/jpad.2023.13.

Amyloid Imaging-Based Food and Drug Administration Approval of Lecanemab to Treat Alzheimer Disease-What Lasts Long Finally Becomes Good?

Barthel H.

J Nucl Med. 2023 Apr;64(4):503-504. doi: 10.2967/jnumed.123.265667. Epub 2023 Mar 23.

Effectiveness and Safety of Pattern Identification-Based Herbal Medicine for Alzheimer's Disease: A Systematic Review and Meta-Analysis

Kim MG, Ooi SL, Kim GW, Pak SC, Koo BS.

J Integr Complement Med. 2023 Oct;29(10):605-620. doi: 10.1089/jicm.2022.0806. Epub 2023 Mar 27.

Accelerated Brain Volume Loss Caused by Anti-β-Amyloid Drugs: A Systematic Review and Meta-analysis

Alves F, Kalinowski P, Ayton S.

Neurology. 2023 May 16;100(20):e2114-e2124. doi: 10.1212/WNL.0000000000207156. Epub 2023 Mar 27.

Brain Shrinkage in Anti-β-Amyloid Alzheimer Trials: Neurodegeneration or Pseudoatrophy?

Barkhof F, Knopman DS.

Neurology. 2023 May 16;100(20):941-942. doi: 10.1212/WNL.0000000000207268. Epub 2023 Mar 27.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias